Fundz

HepQuant Announces Additions to the Executive Leadership Team to Drive Commercialization

PRIVATEJun 13, 2023

Position

Chief Commercial Officer

Company

HepQuant

Carrie Mulherin
carrie.mulherin@hepquant.com
DenverBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics

Description

HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team. Four seasoned executives have joined HepQuant to round out the Company’s leadership team and finalize preparations to launch its quantitative liver function test. HepQuant enables healthcare providers to manage people with liver diseases more effectively and to identify people at risk for liver disease

Quick answer

HepQuant Announces Additions to the Executive Leadership Team to Drive Commercialization (June 13, 2023). HepQuant is based in Denver, Colorado, United States.

What did HepQuant announce on June 13, 2023?
HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team. Four seasoned executives have joined HepQuant to round out the Company’s leadership team and finalize preparations to launch its quantitative liver function test.
What does HepQuant do?
HepQuant is a privately-held, early-stage medical diagnostics company with unique, patented and patent-pending technology for assessing liver function of patients with chronic liver disease.
Where is HepQuant based?
HepQuant is based in Denver, Colorado, United States.
Which similar companies made leadership changes around the same time?
PixCell Medical (June 20, 2023), NorthStar Medical Technologies (June 19, 2023), BIOCEPT INC (June 20, 2023) and Nevro (June 5, 2023) also announced leadership changes within 45 days of HepQuant.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at HepQuant, and when

A new leader at HepQuant brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day HepQuant raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HepQuant, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HepQuant. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HepQuant

Location

Denver, Colorado, United States

About

HepQuant is a privately-held, early-stage medical diagnostics company with unique, patented and patent-pending technology for assessing liver function of patients with chronic liver disease. HepQuant technologies, licensed from the University of Colorado Denver (UCD), have been advanced with the intent to profoundly impact the liver disease landscape – including the research, treatment and patient communities – with diagnostic products that are accurate and minimally invasive. HepQuant products are investigational combination drug / diagnostic devices and have not yet been evaluated or approved by the US Food and Drug Administration (FDA) for commercial sale. They are currently available for investigational use via the FDA IDE application process.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HepQuant changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Carrie
Likely contact at this company
••••••••@••••••••

See Carrie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for HepQuant's next move

Learn about Strategic plan

HepQuant changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.